C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton

Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
12/2001
12/11/2001	US6329548 Aqueous stable lysine solution
12/11/2001	US6329542 Preparation of (S)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
12/11/2001	US6329417 Hepatitis C inhibitor tri-pepitides
12/11/2001	US6329409 Amine derivatives and skin preparations for external use containing the same
12/11/2001	US6329405 As ileal bile acid transporter inhibitor, for therapy of hyperlipemia
12/11/2001	US6329399 Antifungal amine derivatives and processing for producing the same
12/11/2001	US6329379 Oligopeptides for inhibiting hepatitis
12/11/2001	US6329143 Providing a substrate having surface bearing multiple copies of a protective group removable on exposure to an electric field or electric current; applying electric field or current to substrate; exposing to protected monomer, repeating
12/06/2001	WO2001092273A2 Benzenedicarboxylic acid derivatives
12/06/2001	WO2001092213A2 Excitatory amino acid receptor modulators
12/06/2001	WO2001092208A1 Metal-catalysed carboxymethylation in the presence of a promoter
12/06/2001	WO2001092201A1 Substituted phenylpropionic acid derivatives
12/06/2001	WO2001051474A3 Polypharmacophoric agents
12/05/2001	EP1159256A1 Sphingoid base derivatives and uses thereof
12/05/2001	EP1159253A2 Synthesis of nitroalcohol diastereomers
12/05/2001	EP0991793B1 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters
12/05/2001	EP0971880B1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
12/05/2001	CN1325405A Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
12/05/2001	CN1325379A Process for manufacture of L-DOPA ethyl ester
12/05/2001	CN1325378A Process for the synthesis of 1-(aminomethyl) cyclohexyl-acetic acid
12/05/2001	CN1325376A Novel compounds and medicinal use thereof
12/04/2001	US6326479 Synthetic polymers and methods, kits or compositions for modulating the solubility of same
12/04/2001	CA2278883C Very large scale immobilized peptide synthesis
11/2001
11/29/2001	WO2001090048A1 Preparation of enantiomerically enriched amine-functionalized compounds
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	US20010047108 Method for making HBED
11/29/2001	US20010046960 N-(2,2,2-trifluoroethyl)glycine derivatives; can be used to prepare lipophilic proteins adapted for crossing the blood brain barrier
11/28/2001	EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001	EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001	EP1156999A1 Method for the preparation of a chiral-beta-amino ester
11/28/2001	EP0785768B1 O-acyl serines as deodorants
11/27/2001	US6323369 As analgesics
11/27/2001	US6323366 Arylamine synthesis
11/27/2001	US6323180 Protease inhibitors; inhibit replication of hepatitis c virus
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087827A1 Preparation of iminodiacetic acid compounds from monoethanolamine substrates
11/22/2001	WO2001087821A1 Branched amino acids
11/22/2001	WO2001087820A1 Biocidal composition which is an aqueous solution of hydroxymethylaminoacetate
11/22/2001	WO2001087819A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINO ACID AND OPTICALLY ACTIVE α-AMINO ACID AMIDE
11/22/2001	WO2001087806A2 Process for the preparation of aniline compounds
11/22/2001	WO2001087299A1 Aralkyl ester soft drugs
11/22/2001	US20010043942 Aqueous stable lysine solution
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2409253A1 Branched amino acids
11/22/2001	CA2409052A1 Biocidal composition which is an aqueous solution of hydroxymethylaminoacetate
11/22/2001	CA2408839A1 Preparation of iminodiacetic acid compounds from monoethanolamine substrates
11/22/2001	CA2407099A1 Aralkyl ester soft drugs
11/21/2001	EP1156033A1 Process for producing acidic n-(long-chain acyl)amino acid
11/21/2001	EP1156032A1 Optically active amino acid derivatives and processes for the preparation of the same
11/21/2001	EP1155616A1 Process for the preparation of (N-phenylacetyl-N-2,6-xylil)methyl alaninate
11/21/2001	EP1155023A1 Chelating compounds and their complexes with paramagnetic metals
11/21/2001	EP1154987A1 Phenylalaninol derivatives
11/21/2001	EP0912495B1 Asymetric synthesis of chiral beta-amino acids
11/21/2001	EP0641328B1 Bridged aza-bicyclic derivatives as substance p antagonists
11/21/2001	CN1323316A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C
11/21/2001	CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1075050C Process for producing atomiatic olefins
11/20/2001	US6320064 Surfactants for aqueous cleaner systems for cleaning nontextile material with improved fat-removal capacity
11/15/2001	WO2001085692A2 An improved process for the preparation of quinolone derivatives
11/15/2001	WO2001085669A1 Novel spiro[2.4]heptane amino carboxy compounds and derivatives thereof
11/15/2001	CA2407777A1 Novel spiro¬2.4\|heptane amino carboxy compounds and derivatives thereof
11/14/2001	EP1153914A1 Process for the preparation of alkylenediamine-N,N'-disuccinic acid-iron-base complex with pH control
11/14/2001	EP1153029A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
11/14/2001	EP1153010A1 $i(N)-SUBSTITUTED AMINO ACIDS, ANTIOXIDANT PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS USING SAME
11/14/2001	EP1152661A1 Method for increasing the yield of crop plants produce by stimulating germination of pollen grains
11/14/2001	EP0975581B1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate
11/14/2001	EP0971879B1 Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate
11/14/2001	EP0815087B1 Trisubstituted phenyl derivatives
11/14/2001	CN1321636A Process for preparing homophenylalanin derivs
11/13/2001	US6316667 Decyclization of 3-hydroxy-4-butyrolactone to alkyl 4-halogen-3-hydroxybutyrate by reaction with alcohol; cyanation, amidation, cyclization to oxazolidone; hydrolysis, methylation, quaternization
11/13/2001	US6316660 Process for producing cyclohexylamino acids
11/13/2001	US6316658 Quinolone carboxylate chemical intermediates; microbiocides, bactericides
11/13/2001	US6316638 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
11/13/2001	US6316498 For therapy and prophylaxis of psychiatric disorders such as schizophrenia, anxiety, associated diseases, depression, bipolar disturbance and epilepsy, neurological diseases such as drug addiction, cognition disorder, alzheimer's disease
11/13/2001	US6316421 Pentaerythritol lipid derivatives and nuleic-acid complexes
11/08/2001	WO2001083425A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	WO2001083424A1 Tertiary amine methacrylate-based macromonomers and polymers
11/08/2001	WO2001083423A2 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
11/08/2001	WO2001002340B1 Novel aminoindanes
11/08/2001	WO2000017133A3 Lta4 hydrolase inhibitors
11/08/2001	US20010039295 Transfusional iron overload
11/08/2001	US20010039258 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and to form a subcutaneously deliverable supramolecular complex, subcutaneously administering complex
11/08/2001	EP1144348A3 Lta 4? hydrolase inhibitors
11/08/2001	CA2405611A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	CA2402445A1 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
11/07/2001	EP1151997A1 Polychelants, their complexes with metal ions, their preparation and their uses
11/07/2001	EP1151130A1 Coenzymes useful for the synthesis of l-carnitine
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150940A1 N(cf 3?) 2?-anion generation and its use
11/07/2001	EP1003711B1 Novel lipopolyamines, and the preparation and use thereof
11/07/2001	EP0970043B1 Compounds consisting in particular of effectors of the central nervous system receptors sensitive to excitatory amino acids, preparation and biological applications
11/06/2001	US6313174 Aminobenzophenones as inhibitors of interleukin and TNF
11/06/2001	US6313166 Used for pest control, as microbicides, insecticides and acaricides in agriculture, horticulture and in hygiene sector
11/06/2001	US6313159 Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
11/06/2001	US6313150 α-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers

1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 215